{"id":15911,"date":"2012-12-01T20:30:00","date_gmt":"2012-12-01T19:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/teva-indicazioni-deludenti-dalle-stime-2013-45-nel-pre-mercato\/"},"modified":"2012-12-01T20:30:00","modified_gmt":"2012-12-01T19:30:00","slug":"teva-indicazioni-deludenti-dalle-stime-2013-45-nel-pre-mercato","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/teva-indicazioni-deludenti-dalle-stime-2013-45-nel-pre-mercato\/","title":{"rendered":"Teva: disappointing indications from 2013 estimates, -4.5% in the pre-market"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: right; margin: 0cm 0cm 10pt\"><span style=\"line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; font-size: 14pt; mso-fareast-language: IT\"><img decoding=\"async\" id=\"rg_hi\" class=\"rg_hi uh_hi\" alt=\"\" data-width=\"140\" data-height=\"140\" style=\"width: 140px; height: 140px\" src=\"data:image\/jpeg;base64,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\" \/><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><span style=\"line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; font-size: 14pt; mso-fareast-language: IT\">(Finanza.com) Red of 4.5% in the Wall Street pre-market for Israel&#039;s Teva Pharmaceutical. The ADR (American depositary receipt) of the world&#039;s leading generic drug company is penalized by the release of estimates for 2013: according to the company, adjusted profit should amount to 4.85-5.15 dollars while turnover is estimated at 19.5-20.5 billion. The consensus of analysts on Wall Street is for a&nbsp;<span style=\"line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; font-size: 14pt; mso-fareast-font-family: Calibri; mso-fareast-language: IT; mso-fareast-theme-font: minor-latin; mso-ansi-language: IT; mso-bidi-language: AR-SA\">eps\u00b9<\/span> of 5.65 dollars and a turnover of 20.8 billion. <\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><i style=\"mso-bidi-font-style: normal\"><span style=\"mso-fareast-language: IT\"><font size=\"3\"><font face=\"Calibri\">Published November 30, 2012 \u2013 <s\n<\/p>","protected":false},"excerpt":{"rendered":"<p>(Finanza.com) Rosso del 4,5% nel pre-mercato di Wall Stret per l&#8217;israeliana Teva Pharmaceutical. Le Adr (American depositary receipt) della prima azienda al mondo di farmaci generici &egrave; penalizzato dalla diffusione delle stime relative l&rsquo;esercizio 2013: secondo la societ&agrave; l&rsquo;utile adjusted dovrebbe attestarsi a 4,85-5,15 dollari mentre il fatturato &egrave; stimato a 19,5-20,5 miliardi. Il consenso &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-15911","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15911","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=15911"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15911\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=15911"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=15911"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=15911"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}